Skip to content
10-Q

Quarterly Report

MADRIGAL PHARMACEUTICALS, INC. MDGL

0001628280-25-048559

← back to feed
Filed
Nov 4, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 30, 2025 22.71M sh
Shares Diluted Q3 2025 · Sep 30, 2025 22.48M sh
Shares Diluted Q3 2025 · Sep 30, 2025 22.26M sh
Shares Diluted Q3 2025 · Sep 30, 2024 21.75M sh
Shares Diluted Q3 2025 · Sep 30, 2024 21.05M sh
Capex Q3 2025 · Sep 30, 2025 $857K
Capex Q3 2025 · Sep 30, 2024 $1.27M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$56.09M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$351.09M
Long Term Debt Q3 2025 · Sep 30, 2025 $339.75M
Long Term Debt Q3 2025 · Dec 31, 2024 $117.57M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $295.69M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $100.02M
Stockholders Equity Q3 2025 · Sep 30, 2025 $625.73M
Stockholders Equity Q3 2025 · Jun 30, 2025 $695.98M
Stockholders Equity Q3 2025 · Mar 31, 2025 $710.64M
Stockholders Equity Q3 2025 · Dec 31, 2024 $754.38M
Stockholders Equity Q3 2025 · Sep 30, 2024 $777.16M
Stockholders Equity Q3 2025 · Jun 30, 2024 $857.12M
Stockholders Equity Q3 2025 · Mar 31, 2024 $850.76M
Stockholders Equity Q3 2025 · Dec 31, 2023 $405.33M
Current Liabilities Q3 2025 · Sep 30, 2025 $391.41M
Current Liabilities Q3 2025 · Dec 31, 2024 $169.28M
Total Liabilities Q3 2025 · Sep 30, 2025 $736.73M
Total Liabilities Q3 2025 · Dec 31, 2024 $287.86M
Current Assets Q3 2025 · Sep 30, 2025 $1.35B
Current Assets Q3 2025 · Dec 31, 2024 $1.03B
Total Assets Q3 2025 · Sep 30, 2025 $1.36B
Total Assets Q3 2025 · Dec 31, 2024 $1.04B
Eps Diluted Q3 2025 · Sep 30, 2025 −$5.08
Eps Diluted Q3 2025 · Sep 30, 2025 −$10.32
Eps Diluted Q3 2025 · Sep 30, 2024 −$4.92
Eps Diluted Q3 2025 · Sep 30, 2024 −$19.31
Eps Basic Q3 2025 · Sep 30, 2025 −$5.08
Eps Basic Q3 2025 · Sep 30, 2025 −$10.32
Eps Basic Q3 2025 · Sep 30, 2024 −$4.92
Eps Basic Q3 2025 · Sep 30, 2024 −$19.31
Sga Expense Q3 2025 · Sep 30, 2025 $209.12M
Sga Expense Q3 2025 · Sep 30, 2025 $573.85M
Sga Expense Q3 2025 · Sep 30, 2024 $107.59M
Sga Expense Q3 2025 · Sep 30, 2024 $293.83M
Net Income Q3 2025 · Sep 30, 2025 −$114.19M
Net Income Q3 2025 · Sep 30, 2025 −$229.71M
Net Income Q3 2025 · Jun 30, 2025 −$42.28M
Net Income Q3 2025 · Mar 31, 2025 −$73.24M
Net Income Q3 2025 · Sep 30, 2024 −$106.96M
Net Income Q3 2025 · Sep 30, 2024 −$406.48M
Net Income Q3 2025 · Jun 30, 2024 −$151.97M
Net Income Q3 2025 · Mar 31, 2024 −$147.54M
Operating Income Q3 2025 · Sep 30, 2025 −$113.98M
Operating Income Q3 2025 · Sep 30, 2025 −$240.49M
Operating Income Q3 2025 · Sep 30, 2024 −$116.3M
Operating Income Q3 2025 · Sep 30, 2024 −$430.88M
Revenue Q3 2025 · Sep 30, 2025 $287.27M
Revenue Q3 2025 · Sep 30, 2025 $637.32M
Revenue Q3 2025 · Sep 30, 2024 $62.18M
Revenue Q3 2025 · Sep 30, 2024 $76.81M